Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secretin Infusion to Prevent Pancreatic Leaks
NCT02160808Phase 3Completed
- Sponsor
- Dartmouth Health
- Start
- May 2014
- Primary completion
- Sep 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of secretin in Postoperative pancreatic fistula (POPF), sponsored by Dartmouth Health. Started May 2014; status: completed.
02
Drugs
secretin
03
Conditions
Postoperative pancreatic fistula (POPF)
Beyond the preview
Go deeper on NCT02160808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160808.